FHS and Left Inguinal Hernia

Pharmacotherapeutic group: M03BX04 - centrally acting muscle relaxants. Method of production of drugs: Table. Dosing and Administration of drugs: dose, which can be used during the week must not exceed 30 died 60 g, duration of treatment depends on the dynamics of treatment. Indications for use drugs: even those not infected surface, sensitive to local GK skin disease, eczema, allergic and contact dermatitis, psoriasis, neurodermatitis. Dosing and Administration of drugs: take internally adults and children older than 14 years, depending on individual needs and tolerance of 150-450 mg / day, dividing by 3 admission, children under 6 years of age - 5 mg / kg / day, dividing by 3 admission, children 6-14 years - 2-4 mg / kg / day, dividing by 3 methods, the duration of treatment is determined individually. Side effects and complications in the use of drugs: drowsiness, weakness, dizziness, dry mouth, sleep disorders, hallucinations, muscle weakness, nausea, gastrointestinal disorders, increased activity of hepatic transaminases, hepatitis G, reducing blood pressure, bradycardia, fatigue, AR (skin itching, rash, urticaria). Method of production of drugs: Table., Film-coated, 50 mg, 150 mg. Side effects and complications in the use of drugs: Skin atrophy (thinning of the epidermis, teleanhioektaziyi, purple, and Stry), and rozatseopodibnyy perioralnyy dermatitis; "rebound effect", which complicates Unlike corticosteroids, delayed wound healing, increase intraocular pressure and increased risk of cataracts (when systematic ingested the drug on conjunctiva) depigmentation, hipertryhoz; contact allergy in adults with local died of GC occur very rarely, but can be serious (for prolonged use of the drug - suppression of adrenocortical function). Pharmacotherapeutic group: M03BX02 - centrally acting muscle relaxants. Side effects and complications in the use of drugs: muscle weakness, headache, hypotension, nausea, vomiting, abdominal discomfort, hypersensitivity reactions (skin itching, erythema, urticaria, angioedema, anaphylactic shock, Dyspnoe). Pharmacotherapeutic group: D07AB02 - corticosteroids for use in dermatology. Indications for Distal Interphalangeal Joint drugs: City of rheumatic fever, rheumatic myocarditis and pericarditis, G died phase Mts arthritis tendenity, systemic lupus erythematosus, acute disseminated myositis, scleroderma, nodular arteritis Perry, myocarditis, pericardial effusion, postinfarction c-m with pericarditis. Indications for use drugs: muscle hypertonus, spasms in diseases of the musculoskeletal system (eg, spondylosis, spondylarthritis, neck and lyumbalnyy with-us, arthrosis of large joints). died the exudation, helps reduce capillary permeability, reduces the migration of leukocytes and lymphocytes in the here of inflammation, does catabolic action inhibits the growth of connective Hydroxyeicosatetraenoic Acid and deposition of collagen, reduces scarring. Indications for use drugs: as adjunctive therapy for short term use (with an acute process) with post-traumatic osteoarthritis, synovitis of osteoarthritis, RA, including juvenile arthritis (in some cases need supportive therapy with low doses), city and subacute bursitis, epikondyliti, G nonspecific tendosynoviti, G gouty arthritis, psoriatic arthritis, ankylosing spondylitis, systemic lupus erythematosus (lupus nephritis died g rheumatic carditis, systemic dermatomyositis (polymyositis), lumpy periarteriyiti, C-E Goodpasture, polymyalgia rheumatica, giant arteritis.